TABLE 1.
Prevalence and demographic characteristics of viral hepatitis markers among patients with jaundice who tested negative for yellow fever in the DRCa
| Characteristic | HBV surface Agb (n = 470) | Anti-HBcc IgM (n = 444) | HDV Ag + total Abd (n = 84) | HCV Ag + total Ab (n = 379) | HAV IgM (n = 432) | HEV IgM (n = 365) |
|---|---|---|---|---|---|---|
| Overall prevalence (% [95% CI]) | 22.3 (18.5–26.0) | 11.0 (8.1–13.9) | 26.1 (16.6–35.5) | 2.3 (0.8–3.8) | 16.7 (13.2–20.2) | 10.4 (7.3–13.5) |
| Sex (female/male, 0.8:1) | ||||||
| Male | 65/257 (25.2) | 23/243 (9.4) | 13/49 (26.5) | 5/201 (2.4) | 39/233 (16.7) | 25/195 (12.8) |
| Female | 40/213 (18.7) | 26/201 (12.9) | 9/35 (25.7) | 4/178 (2.2) | 33/199 (16.5) | 13/170 (7.6) |
| Age (mean, 22.4 yr; range, 4 mo to 77 yr) | ||||||
| 0–5 yr | 13/118 (11) | 7/107 (6.5) | 2/10 (20) | 2/90 (2.2) | 46/108 (42.5) | 0/87 (0) |
| 6–15 yr | 14/78 (17.9) | 6/76 (7.8) | 2/12 (16.6) | 0/64 (0) | 21/74 (28.3) | 2/67 (2.9) |
| 16–40 yr | 59/184 (32) | 29/176 (16.4) | 12/45 (26.6) | 3/146 (2) | 4/166 (2.4) | 22/142 (15.4) |
| >40 yr | 19/90 (21.1) | 7/85 (8.2) | 6/17 (35.2) | 4/79 (5) | 1/84 (1.1) | 14/69 (20.2) |
| Province of origin | ||||||
| Bandundu | 9/34 (26.4) | 8/34 (23.5) | 0/8 (0) | 0/22 (0) | 4/32 (12.5) | 0/29 (0) |
| Bas-Congo | 4/14 (28.5) | 2/13 (15.3) | 0/3 (0) | 0/10 (0) | 5/13 (38.4) | 0/11 (0) |
| Equateur | 31/121 (25.6) | 11/112 (9.8) | 9/27 (33.3) | 1/99 (1) | 12/116 (10.3) | 28/98 (28.5) |
| Kasai-Occidental | 12/48 (25) | 7/47 (14.8) | 0/13 (0) | 1/31 (3.2) | 4/45 (8.8) | 8/37 (21.6) |
| Kasai-Oriental | 9/52 (17.3) | 6/54 (11.1) | 1/8 (12.5) | 1/40 (2.5) | 8/54 (14.8) | 1/44 (2.2) |
| Katanga | 0/6 (0) | 0/6 (0) | 0/0 | 0/6 (0) | 0/6 (0) | 0/3 (0) |
| Kinshasa | 3/21 (14.2) | 2/21 (9.5) | 1/2 (50) | 0/14 (0) | 4/21 (19) | 0/15 (0) |
| Maniema | 0/11 (0) | 0/11 (0) | 0/0 | 1/10 (10) | 2/11 (18.1) | 0/9 (0) |
| Nord-Kivu | 0/11 (0) | 0/11 (0) | 0/0 | 0/10 (0) | 1/11 (9) | 0/11 (0) |
| Orientale | 37/152 (24.3) | 13/135 (9.6) | 11/23 (47.8) | 5/137 (3.6) | 32/123 (26) | 1/108 (0.9) |
a
Data are number of samples testing positive/total number of antibodies tested (%) unless stated otherwise.
b
Ag, antigen.
c
Hbc, hepatitis B core protein.
d
Ab, antibody.